New tool helps families cut back on kids' risky psychiatric drugs

NCT ID NCT07392489

Completed Symptom relief Sponsor: Glyn Jones-Elwyn Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called AWARE that helps caregivers and doctors review children's psychiatric medications and decide whether to lower or stop some of them. The goal is to reduce harm from side effects like weight gain and diabetes. 31 children aged 6-17 who were on multiple medications or antipsychotics took part. The program includes a medication review handout and a guide for safely tapering drugs if chosen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDREN PATIENT DECISION AID PSYCHIATRIC DRUGS PSYCHOTROPIC DRUGS SHARED DECISION MAKING

Contacts and locations

Locations

Cayuga County Community Mental Health Center

Auburn, New York, 13021, United States
Clinton County Mental Health & Addiction Services

Plattsburgh, New York, 12903, United States
Dartmouth College

Hanover, New Hampshire, 03755, United States
Dartmouth Health

Lebanon, New Hampshire, 03766, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.